Philip Morris International is under renewed scrutiny as Brazil's landmark public health lawsuit moves closer to a liability ruling, adding legal risk to the investment picture. The stock has pulled back 6.6% over the past week, even as it posted a 9.6% return over 90 days and an 18% total shareholder return over one year. A widely followed narrative pegs the company's fair value at $193.14, about 3.2% above its last close of $186.91, supported by strong double-digit volume and margin growth in smoke-free platforms like IQOS, ZYN, and VEEV. However, Philip Morris International's current price-to-earnings ratio of 26.9 times sits well above the global tobacco industry average of 12.1 times and peer average of 18.7 times, raising questions about whether the upside is already priced in. Investors are weighing the secular shift toward smoke-free alternatives against risks such as tougher regulation and any slowdown in adoption.
Philip Morris International IncBrazil lawsuit liability ruling adds legal risk
